CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RHHBY

PDS Implant Pre-Filled with Ranibizumab

Phase 3
Roche Holding AG (RHHBY)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q3 '27
RHHBYPhase 3

PDS Implant Pre-Filled with Ranibizumab Phase 3 Est. Readout (Pagoda)

PDS Implant Pre-Filled with Ranibizumab
Q3 2027~Q
CT.gov
00%
Competitive Landscape

2 competitors in Diabetic Retinopathy

View Full Landscape
Drug Information

Target Indication

Diabetic Retinopathy

Clinical Trial

NCT04503551

Last updated: 10/16/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.